Chemotherapy remains a cornerstone of cancer treatment; however, its administration is often associated with debilitating side effects, including fatigue, nausea, alopecia, neuropathy, and immunosuppression, which significantly impact patients’ quality of life. With the increasing shift toward outpatient chemotherapy, there is a critical need for effective symptom management strategies. This study underscores the role of self-management tools in enhancing patient care during chemotherapy. Existing digital health solutions, including mHealth applications, telemedicine, and drug-tracking platforms, have shown promise in symptom monitoring and remote care. This paper presents an integrated solution that combines a wearable device with a mobile application to enable real-time monitoring of vital signs and symptoms, facilitating timely interventions. By enhancing personalized care and improving treatment outcomes, this approach empowers patients in managing their health more effectively while supporting healthcare providers in delivering proactive and responsive care.
Srimathi et al. (Mon,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: